NASDAQ
Editas Medicine, Inc. (EDIT) has a revenue compound annual growth rate of -14.89% over 5 years and 37.90% over 10 years. Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.
No price data available for this timeframe.